THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (100K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 1 sale
Filed: 6/21/2022ACC: 0001493152-22-017382
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-100K
Net shares
Net seller
$0.00
Total acquired
1
Open market trades
0B · 1S
1
Total transactions
100K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−100K
Price / share
—
Trade value
—
% of position
0.0%
6/17/2022
202.66M→202.56M
Total
Net shares
−100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2022 | S · Sale | −100K | — | — | 0.0% | 202.66M | 202.56M |
| Total | −100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported